Abstract
OBJECTIVE High-grade gliomas (HGGs) inevitably recur and progress despite resection and standard chemotherapies and radiation. Viral therapies have emerged as a theoretically favorable adjuvant modality that might overcome intrinsic factors of HGGs that confer treatment resistance.
Author supplied keywords
Cite
CITATION STYLE
APA
Wang, J. L., Scheitler, K. M., Wenger, N. M., & Elder, J. B. (2021). Viral therapies for glioblastoma and high-grade gliomas in adults: a systematic review. Neurosurgical Focus, 50(2), 1–14. https://doi.org/10.3171/2020.11.FOCUS20854
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free